Activity aim
This clinical audit seeks to improve vaccination protection for RSV in older people, with a specific focus on patients who are at increased risk of RSV-related complications due to comorbid conditions they may have. It will involve the review of five patients either through active recall or as part of a routine health check, at which point the GP will work through a practice checklist with recommendations relevant to the individual patient.
Why take part in this program?
- Access a comprehensive pre-learning activity including experts such as Professor Paul Griffin, Professor Lucy Morgan and A/Prof Michael Woodward.
- Conduct follow-up consultations with 5 patients over 60 years of age, who have not received RSV vaccination in the past two years, and/or the need for revaccination has not been established.
- Earn 6.5 CPD hours upon completion.
Inclusion criteria
Patients who are eligible for this clinical audit are adults who are:
- Adults aged 60 years or older
- Have not received RSV vaccination in the past two years, and/or the need for revaccination has not been established
- Have no absolute contraindications to RSV vaccination (anaphylaxis after a previous dose of the same RSV vaccine, or anaphylaxis after any component of an RSV vaccine)
How long should it take?
The program has been designed to take approximately 4-6 weeks to complete. This includes patient recall from your practice, patient consult and program evaluation.
Tips to recruit patients
Recruitment may occur:
- Opportunistically as you consult appropriate patients as part of usual care.
- By active recall.
Boost your Measuring Outcomes CPD hours with this new clinical audit
Learning outcomes
Presenters
Professor Griffin is an infectious diseases physician and clinical microbiologist, the Director of Infectious Diseases at Mater Health Services, and conjoint Head of the Mater Clinical Unit for the University of Queensland School of Medicine. He is an accomplished clinical trial investigator, particularly in infectious diseases, including novel vaccines and COVID-19 vaccines. He also serves as a board member and scientific advisory board member of the Immunisation Coalition, becoming a trusted media authority and spokesperson nationwide during the COVID-19 pandemic.
Professor Lucy Morgan is an adult respiratory and sleep physician. Lucy is a proud graduate of the University of Newcastle, trained at Concord Hospital and completed a PhD in chronic lung disease at the University of Sydney. Her clinical practice covers a wide range of lung problems including airways diseases (asthma and COPD, bronchiectasis), pulmonary fibrosis, lung infections and lung cancer. Lucy is committed to a multidisciplinary approach to respiratory health care and has strong links to other clinicians.
Lucy has academic appointments at Macquarie University and Sydney University with a strong interest in teaching and training junior doctors and lung researchers throughout the Macquarie University Hospital, Nepean Hospital and Concord Hospital Clinical Schools. Lucy has a very active clinical research portfolio. She is chair of the Australasian Bronchiectasis Consortium and the clinical lead for the Australian Bronchiectasis Registry project. She is currently the president of the NSW TSANZ , is a Director of Lung Foundation Australia, a member of the Australian Lung Cancer Trials Group and Director of Research for the Nepean Lung Cancer Group. She is widely published and an invited speaker at National and International conferences.
A/Prof Woodward is Head of Dementia Research at Austin Health. He specialises in geriatric medicine with a major interest in adult vaccination, as well as Alzheimer’s disease and other dementias, wound management, and the quality use of medications in older people. He has published extensively and has been heavily involved in many journals and professional organisations throughout his illustrious career. His work in geriatric medicine, dementia and other research and his extensive authorship has been honoured with Membership of the Order of Australia.
Related content
